U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C10H16O4S.C8H19N
Molecular Weight 361.54
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OCTODRINE CAMSILATE

SMILES

CC(C)CCCC(C)N.CC1(C)[C@@H]2CC[C@@]1(CS(O)(=O)=O)C(=O)C2

InChI

InChIKey=IJUZWPVVLRFXDI-YZUKSGEXSA-N
InChI=1S/C10H16O4S.C8H19N/c1-9(2)7-3-4-10(9,8(11)5-7)6-15(12,13)14;1-7(2)5-4-6-8(3)9/h7H,3-6H2,1-2H3,(H,12,13,14);7-8H,4-6,9H2,1-3H3/t7-,10-;/m1./s1

HIDE SMILES / InChI

Molecular Formula C10H16O4S
Molecular Weight 232.297
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula C8H19N
Molecular Weight 129.2432
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/6891293 | https://www.ncbi.nlm.nih.gov/pubmed/14881080

Octodrine is a stimulant that is structurally similar to amphetamine and is included in several so-called “pre-workout” and “fat-burning” supplements. Octodrine, has a history of use as a pharmaceutical drug. It was originally developed in the United States as an aerosolized treatment for bronchitis, laryngitis and other conditions Initially approved by the FDA in 1946 as Eskay’s Oralator, this inhaler appeared only in the 1949 edition of the Physicians’ Desk Reference. Octodrine was combined with several other medications, including theophylline, 3-octopamine, and adenosine, in multi-ingredient tablets sold between the early 1960s through the mid-2000s under the trade names Ambredin, Ordinal, Ordinal Retard and Ordinal Forte. Some proponents say octodrine is a safer alternative to other stimulants like ephedra and Dimethylamylamine (DMAA), but there is no scientific information to support this claim. Originally developed in the early 1950’s as a remedy to nasal congestion and as a possible anti-tumor drug, Octodrine has resurfaced as a key ingredient in dietary supplements for its stimulant and thermogenic benefits.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Separation and conductimetric detection of C1-C7 aliphatic monocarboxylic acids and C1-C7 aliphatic monoamines on unfunctionized polymethacrylate resin columns.
2004 Jun 11
On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors.
2009 Nov 1
Patents

Patents

Sample Use Guides

Maximum daily intake 8.5 g
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 11:07:00 GMT 2023
Edited
by admin
on Sat Dec 16 11:07:00 GMT 2023
Record UNII
R667VG3A97
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OCTODRINE CAMSILATE
WHO-DD  
Common Name English
AMC
Common Name English
2-AMINO-6-METHYLHEPTANE (+)-CAMPHOR-10-SULFONATE
Common Name English
2-HEPTANAMINE, 6-METHYL-, (1S)-7,7-DIMETHYL-2-OXOBICYCLO(2.2.1)HEPTANE-1-METHANESULFONATE HEXYLAMINE, 1,5-DIMETHYL-, (+)-2-OXO-10-BORNANESULFONATE
Common Name English
BICYCLO(2.2.1)HEPTANE-1-METHANESULFONIC ACID, 7,7-DIMETHYL-2-OXO-, (1S)-, COMPD. WITH (±)-6-METHYL-2-HEPTANAMINE (1:1
Common Name English
BICYCLO(2.2.1)HEPTANE-1-METHANESULFONIC ACID, 7,7-DIMETHYL-2-OXO-, (1S,4R)-, COMPD. WITH 6-METHYL-2-HEPTANAMINE (1:1)
Systematic Name English
10-BORNANESULFONIC ACID, 2-OXO-, COMPD. WITH 1,5-DIMETHYLHEXYLAMINE (1:1), (+)- BICYCLO(2.2.1)HEPTANE-1-METHANESULFONIC ACID, 7,7-DIMETHYL-2-OXO-, (1S)-, COMPD. WITH 6-METHYL-2-HEPTANAMINE (1:1)
Common Name English
Octodrine camsilate [WHO-DD]
Common Name English
Code System Code Type Description
FDA UNII
R667VG3A97
Created by admin on Sat Dec 16 11:07:01 GMT 2023 , Edited by admin on Sat Dec 16 11:07:01 GMT 2023
PRIMARY
PUBCHEM
118984358
Created by admin on Sat Dec 16 11:07:01 GMT 2023 , Edited by admin on Sat Dec 16 11:07:01 GMT 2023
PRIMARY
ECHA (EC/EINECS)
217-820-1
Created by admin on Sat Dec 16 11:07:01 GMT 2023 , Edited by admin on Sat Dec 16 11:07:01 GMT 2023
PRIMARY
SMS_ID
100000085934
Created by admin on Sat Dec 16 11:07:01 GMT 2023 , Edited by admin on Sat Dec 16 11:07:01 GMT 2023
PRIMARY
EVMPD
SUB03487MIG
Created by admin on Sat Dec 16 11:07:01 GMT 2023 , Edited by admin on Sat Dec 16 11:07:01 GMT 2023
PRIMARY
CAS
1971-57-9
Created by admin on Sat Dec 16 11:07:01 GMT 2023 , Edited by admin on Sat Dec 16 11:07:01 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY